Howard Lin

St. Jude Children's Research Hospital — United States

Medicine · Health Sciences

22h-index1.6kcitations47works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Histiocytic Disorders and Treatments(21), Sarcoma Diagnosis and Treatment(9), Extracellular vesicles in disease(7), Lymphoma Diagnosis and Treatment(6), Genetic and rare skin diseases.(6)

Publications47 total

Late-Onset Retinoblastoma
Ophthalmology Retina·2025
The global, regional, and national burden of soft tissue sarcomas and other extraosseous sarcomas, 1990-2021: A systematic analysis for the Global Burden of Disease study 2021.
Journal of Clinical Oncology·2025
Multilevel mortality risk factors among pediatric hematology‐oncology patients with deterioration
Cancer·2025· 2 citedOpen Access
<i>BRAF</i> V600E-positive mononuclear cells in blood at diagnosis portend treatment failure and neurodegeneration in pediatric LCH
Blood·2025· 7 cited
Delayed Periocular and Anterior Segment Complications Following Locally Administered Chemotherapy for Vitreous Seeding in Retinoblastoma
Seminars in Ophthalmology·2025· 1 cited
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis
British Journal of Haematology·2024· 13 citedOpen Access
Clinical, radiological and molecular responses to combination chemotherapy with <scp>MAPK</scp> pathway inhibition in relapsed and refractory Langerhans cell histiocytosis
British Journal of Haematology·2024· 11 citedOpen Access
Abstract B073: Leveraging genomic diversity identifies additional germline risk loci in <i>SMAD6</i> for Langerhans cell histiocytosis
Cancer Epidemiology Biomarkers & Prevention·2023
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders
Immunity·2023· 39 citedOpen Access
Expanded Assessments of Germline Genetic Variants Identify Additional Risk Loci for Langerhans Cell Histiocytosis
Blood·2023· 1 cited
Responses to Combination Chemotherapy with MAPK Pathway Inhibition in Relapsed and Refractory LCH
Blood·2023· 1 citedOpen Access
Retrospective Analysis of Clofarabine Salvage Therapy in Refractory Multifocal Langerhans Cell Histiocytosis (LCH)
Blood·2023· 1 cited
Identification of Germline, Ancestry-Specific Variants for Langerhans Cell Histiocytosis in Hispanic Patients
Blood·2023Open Access
<i>First Blood</i>: Pre-Therapy <i>BRAF</i>V600E+ PBMC Identifies a Novel Clinical Risk Category for Patients with LCH
Blood·2023Open Access
Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration
2023· 2 citedOpen Access
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT
Blood Advances·2023· 4 citedOpen Access
Fine-Mapping of <i>SMAD6</i> Sequence Data Identifies Additional Putative Risk Loci for Langerhans Cell Histiocytosis
Blood·2022
Ultrasonographic Inferior Vena Cava Measurement is More Sensitive Than Vital Sign Abnormalities for Identifying Moderate and Severe Hemorrhage
Journal of Emergency Medicine·2021· 3 cited
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
Blood Advances·2021· 57 citedOpen Access
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
Nature Medicine·2021· 76 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Kenneth L. McClain(23), Carl E. Allen(23), Brooks Scull(16), Olive S. Eckstein(13), Harshal Abhyankar(11), Rikhia Chakraborty(9), Miriam Mérad(9), Tsz‐Kwong Man(9), Daniel Zinn(7), Jennifer E. Agrusa(7), Nitya Gulati(7), Catherine A. Billups(6), Erin C. Peckham‐Gregory(6), Nader Kim El‐Mallawany(6), Jennifer Picarsic(5), Karen Phaik Har Lim(5), Michael E. Scheurer(5), Victor M. Santana(4), Markus G. Manz(4), Sérgio A. Lira(4)